1.09
price down icon1.80%   -0.02
pre-market  Vorhandelsmarkt:  1.06   -0.03   -2.75%
loading

Finanzdaten der Renovorx Inc-Aktie (RNXT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
162.14%
0.27
0.103 0.043 - -
Operating Expenses
8.25%
2.948
3.213 2.675 2.828 3.034
Benefits Costs and Expenses
25.45%
3.165
2.523 - - -
Costs And Expenses
8.25%
2.948
3.213 - - -
Operating Income/Loss
13.89%
-2.678
-3.11 -2.632 -2.828 -3.034
Nonoperating Income/Loss
131.45%
-0.217
0.69 -0.246 0.357 0.645
Income/Loss From Continuing Operations Before Tax
19.63%
-2.895
-2.42 -2.878 -2.471 -2.389
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
19.63%
-2.895
-2.42 -2.878 -2.471 -2.389
Net Income/Loss
19.63%
-2.895
-2.42 -2.878 -2.471 -2.389
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
16.50%
36.58
31.40 0.9455 24.94 24.05
Diluted Average Shares
16.50%
36.58
31.40 0.9455 24.94 24.05
Basic Earnings Per Share
0.00%
-0.08
-0.08 -0.12 -0.10 -0.10
Diluted Earnings Per Share
0.00%
-0.08
-0.08 -0.12 -0.10 -0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):